ABSTRACT
Background: Although vaccines have been launched, COVID-19 has not been effectively curbed, and the number of infections is increasing. Compared with western medicine, Traditional Chinese Medicine has made some achievements in the treatment of COVID-19, which should be paid attention to and play a greater role. As a classical Chinese medicine prescription for treating pestilence, Lianhuaqingwen (LHQW) has gone to many countries with the Chinese medical team to participate in the local fight against the epidemic, which has been widely recognized. Method(s): We searched MEDLINE, EMBASE, AMED, Chchrane Central Register of Controlled Trials (CENTRAL), PubMed, Web of Science, Chinese National Knowledge Infrastructure (CNKI), VIP Information Database (VIP), Chinese Biomedical Literature Database (CBM), and Wanfang Database from inception up to November 24, 2021, which formed the basis for evidence used to formulate recommendations. Sixteen randomized controlled trials (RCTs) involving 1896 patients were enrolled. LHQW is a traditional Chinese medicine compound preparation, which contains 13 traditional Chinese medicine (TCM) components. Two dosage formulations of LHQW were included: granule and capsule. The most commonly used dosage formulation was granule (15/17, 88.24%), followed by capsule (2/17, 11.76%). Conclusion(s): This systematic review and Meta analysis suggested that, in the treatment of COVID-19, LHQW Capsule (Granule) could not only significantly improve the fever symptoms, shorten the fever time, but also reduce the cough and fatigue symptoms, improve the clinical efficiency, improve the lung CT, significantly reduce the number of patients with mild to severe diseases, and have certain anti-inflammatory effect. And there is no server adverse events which support the safety of LHQW Capsule (Granule) for the treatment of COVID-19. As a classic formula of TCM, LHQW Capsule (Granule) could be used as potential candidates for COVID-19 in this battle.Copyright © 2022
ABSTRACT
Surface subsidence is a serious threat to human life, buildings and traffic in Beijing. Surface subsidence is closely related to human activities, and human activities in Beijing area showed a decreasing trend during the Corona Virus Disease 2019 (COVID-19). To study surface subsidence in Beijing before and after the COVID-19 outbreak and its causes, a total of 51 Sentinel-1A SAR images covering Beijing from January 2018 to April 2022 were selected to derive subsidence information by Time Series Interferometry Synthetic Aperture Radar (TS-InSAR). The results of surface subsidence in Beijing demonstrate that Changping, Chaoyang, Tongzhou and Daxing Districts exhibited the most serious subsidence phenomenon before the COVID-19 outbreak. The four main subsidence areas form an anti-Beijing Bay that surrounds other important urban areas. The maximum subsidence rate reached −57.0 mm/year. After the COVID-19 outbreak, the main subsidence area was separated into three giant subsidence funnels and several small subsidence funnels. During this period, the maximum subsidence rate was reduced to −43.0 mm/year. Human activity decrease with the COVID-19 outbreak. This study effectively analysed the influence of natural factors on surface subsidence after excluding most of the human factors. The following conclusions are obtained from the analysis: (1) Groundwater level changes, Beijing's geological structure and infrastructure construction are the main reasons for surface subsidence in Beijing. (2) Seasonal changes in rainfall and temperature indirectly affect groundwater level changes, thereby affecting surface subsidence in the area. (3) The COVID-19 outbreak in early 2020 reduced the payload of Beijing's transportation facilities. It also slowed down the progress of various infrastructure construction projects in Beijing. These scenarios affected the pressure on the soft land base in Beijing and reduced the surface subsidence trend to some extent. © 2023 by the authors.
ABSTRACT
Laboratory diagnostics is a booming medical applied subjects. With the continuous enrichment of the content and the enhancement of its role in diagnosis, it has increasingly become a compulsory course for all medical students. Because the subject has many individual theoretical disciplines and application technologies, the traditional on-site teaching mode has been greatly challenged. Especially under the background of the pandemic, it is more difficult for the teaching by the online course totally. For this reason, the measures of key sessions,such as through preparation and peer review before the class, online question and answer between teachers and students, reviewing homework after the class and recording video for probation purpose were summarized and reviewed. The online course mode was supposed to realize "non-stop teaching during pandemic", but also realize the double guarantee of teaching plan and teaching effect, which provide experience for expanding the whole network course of laboratory diagnostics.
ABSTRACT
AIM: To study the regularity and characteristics of side effects of lopinavir/ritonavir for COVID-19. METHODS: The type of side effects, general information, medical history and prognosis in 61 confirmed and suspected COVID-19 patients with lopinavir/ritonavir were analyzed. RESULTS: Among the 61 patients, 41(67.21%) had lopinavir/ritonavir related side effects, mainly manifested as gastrointestinal reactions (82.93%) and liver function damage (53.66%). Old age, long course of disease and chronic gastrointestinal disease are independent risk factors for side effects. CONCLUSION: Lopinavir/ritonavir has a high incidence of side effects and can be used in COVID-19 patients under the condition of close observation of the patient's symptoms and test results. Special population should improve pharmaceutical care to ensure the safety of drug use.